JPRN-UMIN000004635已完成2 期
A Phase II first-line study of Carboplatin plus Pemetrexed in elderly patients with advanced non-small, non-squamous cell lung cancer - A Phase II first-line study of CBDCA plus PEM in elderly patients with advanced non-small, non-squamous cell lung cancer
Kochi University, School of Medicine, Department of Hematology and Resporatory Medicine0 个研究点目标入组 35 人开始时间: 2010年12月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Squamous cell carcinoma 2) Cases with previous radiation therapy against primary tumor 3) Patients with superior vena cava (SVC) syndrome 4) Patients with severe drug allergy 5) Patients with massive and/or uncontrollable pleural effusion 6) Patients with massive ascites, or pericardial effusion 7) Patients with active severe infections 8) Patients with active lung disease such as interstitial pneumonia or lung fibrosis 9) Patients with symptomatic brain metastasis 10) Patients with active concomitant malignancy 11) Patients with uncontrollable complications such as psychiatric problems 12) Inappropriate patients for this study judged by the physicians
研究者
相似试验
招募中
1 期
A Phase 2 study of Carboplatin plus Pemetrexed plus Bevacizumab as first-line therapy for stage3B/4 non-squamous non-small-cell lung cancerung CancerJPRN-UMIN000005143Dokkyo Medical University30
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
2 期
A phase II study of carboplatin plus pemetrexed followed by gefitinib for stage IIIB/IV non-small cell lung cancer with EGFR mutationon-small cell lung cancer with EGFR mutationJPRN-UMIN000003354Kanagawa Cancer Center60
招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung CancerJPRN-UMIN000016730Foundation for Biomedical Research and Innovation43
进行中（未招募）
不适用
Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer - NDEUCTR2007-000913-13-ITELI LILLY47